Salicylic Acid

Salicylic Acid

SCHEMBL1904685

O=C(O)c1ccccc1O.O=C(O)c1ccccc1O.OCCN(CCO)CCO.OCCN(CCO)CCO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.67
ALDH1A1 P00352 6/20 0.67
HPGD P15428 6/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
CA12 O43570 1/20 0.67
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
HMGB1 P09429 1/20 0.67
CA4 P22748 1/20 0.67
CA6 P23280 1/20 0.67
CA7 P43166 1/20 0.67
CA9 Q16790 1/20 0.67
NAPRT Q6XQN6 1/20 0.67
CA14 Q9ULX7 1/20 0.67
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 4/20 0.46
TSHR P16473 2/20 0.46
LMNA P02545 2/20 0.45
ALOX12 P18054 1/20 0.45
G6PD P11413 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicylic Acid SCHEMBL15847 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL5874177 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL5313430 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL19717848 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL10788832 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL15717117 1.00 KDM4E (0.67) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL2595372 0.98 KDM4E (0.64) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL1131781 0.89 KDM4E (0.53) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Salicylic Acid SCHEMBL6653091 0.89 KDM4E (0.53) KDM4EALDH1A1HPGDSMN1; SMN2CA12
Phthalic Acid SCHEMBL5875171 0.88 ALDH1A1 (0.61) KDM4EALDH1A1HPGDSMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493462-A1 PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURES Green Molecular, S.L. (ES) 2012-09-05 EP disclosed
WO-2011051483-A1 PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURES GREEN MOLECULAR, S.L (ES) 2011-05-05 WO disclosed
EP-1324821-A2 EMULSION COMPRISING A BLEND OF CATIONIC, ANIONIC AND BRIDGING SURFACTANS, OIL AND WATER STEPAN COMPANY (US) 2003-07-09 EP disclosed
EP-1318720-A2 ANTIMICROBIAL TERNARY SURFACTANT BLEND COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS, AND METHODS OF PREPARING SAME STEPAN COMPANY (US) 2003-06-18 EP disclosed
WO-2002022083-A2 EMULSION COMPRISING A BLEND OF CATIONIC, ANIONIC AND BRIDGING SURFACTANTS, OIL AND WATER STEPAN COMPANY (US) 2002-03-21 WO disclosed
WO-2002021916-A2 ANTIMICROBIAL TERNARY SURFACTANT BLEND COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS, AND METHODS OF PREPARING SAME STEPAN COMPANY (US) 2002-03-21 WO disclosed
EP-0814760-A1 SUBSTITUTED o-AMINOCARBONYLBENZOIC ACID SALTS AND THEIR USE AS SUNSCREENS STEPAN COMPANY (US) 1998-01-07 EP disclosed
WO-1997025971-A1 SUBSTITUTED o-AMINOCARBONYLBENZOIC ACID SALTS AND THEIR USE AS SUNSCREENS STEPAN COMPANY (US) 1997-07-24 WO disclosed